3rd Quarter - Report

HARM REDUCTION COALITION for HARM REDUCTION COALITION

Period 3rd Quarter 2014 Filed Oct 31, 2014 Signed by WHITNEY ENGLANDER

Official filing
Firm
HARM REDUCTION COALITION
Client
HARM REDUCTION COALITION
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Opioid overdose prevention measures, including the expanded access of naloxone. Reduce barriers to medication assisted treatment; suboxone/buprenorphine.

LobbyistCovered position, as disclosed
WHITNEY ENGLANDER —

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA)

Health Issues HCR

Hepatitis C prevention, testing and treatment.

LobbyistCovered position, as disclosed
WHITNEY ENGLANDER —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.